ESMO Clinical Practice Guidelines: Supportive and Palliative Care

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.

Latest enhanced and revised set of guidelines

Supportive and palliative care are areas of high importance in oncology and ESMO published Clinical Practice Guidelines on the management of a variety of issues: Management of infusion reactions to systemic anticancer therapy, Management of toxicities from immunotherapy, Management of febrile neutropaenia, MASCC and ESMO consensus guidelines for the prevention of chemotherapy and radiotherapy-induced nausea and vomiting, Treatment of dyspnoea in advanced cancer patients, Central venous access in oncology, Management of oral and gastrointestinal mucosal injury, Management of refractory symptoms at the end of life and the use of palliative sedation, Advanced care planning in palliative care, Bone health in cancer patients, Cancer, fertility and pregnancy, Management of chemotherapy extravasation, Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy, Management of cancer pain, Management of venous thromboembolism in cancer patients, Prevention of chemotherapy and radiotherapy-induced nausea, Erythropoiesis-stimulating agents in the treatment of anaemia in cancer patients, Haematopoietic growth factors.